Zydus Lifesciences has reported results for the fourth quarter (Q4FY26) and year ended March 31, 2026.
The company has reported 38.80% fall in its net profit at Rs 1,722.00 crore for the fourth quarter ended March 31, 2026 as compared to Rs 2,813.70 crore for the same quarter in the previous year. The total income of the company has decreased by 29.46% at Rs 4,236.00 crore for Q4FY26 as compared to Rs 6,005.00 crore for the corresponding quarter previous year.
On consolidated basis, the company has reported 8.68% rise in its net profit at Rs 1,272.50 crore for the fourth quarter ended March 31, 2026 as compared to Rs 1,170.90 crore for the same quarter in the previous year. The total income of the company increased by 16.84% at Rs 7,721.20 crore for Q4FY26 as compared to Rs 6,608.50 crore for the corresponding quarter previous year.
For the year ended March 31, 2026, the company has reported 38.36% fall in its net profit at Rs 3,559.80 crore as compared to Rs 5,774.90 crore for the previous year. The total income of the company has decreased by 16.83% at Rs 13,151.50 crore for year under review as compared to Rs 15,812.50 crore for year ended March 31, 2025.
For the year ended March 31, 2026, on the consolidated basis, the company has reported 11.37% rise in its net profit at Rs 5,040.00 crore as compared to Rs 4,525.50 crore for the previous year. The total income of the company increased by 17.64% at Rs 27,657.90 crore for year under review as compared to Rs 23,511.00 crore for year ended March 31, 2025.
